clinical_trials
STAT+: Most-favored nations policy makes drugmakers rethink launches abroad
Confidence88·multiple reportsImportance90NP-EVT-20261111-698D13B
Drug companies seem to be looking for workarounds to protect their U.S. sales against Trump's "most-favored nations" policy:
Read the original at the primary source
STAT+: Most-favored nations policy makes drugmakers rethink launches abroad
Elaine Chen · 11/11/2026, 7:44:07 PM
Also on the network: airlinesairports · farmerspulse · foodpulse · indianhealthpulse · indias · keralahealth · naturepulse · travelerpulse
Discussion
ChatsPulse · 0 threads
No discussion yet. Sign in and start the first thread —